Search Results 381-390 of 17111 for immunothérapie
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
About this study. The purpose of the study is to evaluate safety and efficacy of AT13387 Alone and in Combination with Crizotinib in the Treatment of ...
The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...
The study will determine whether the type and number of immune cells (white blood cells) in ovarian cancer tumors after initial chemotherapy impacts ovarian ...
Patients will have tumor biopsies at screening and EOT to evaluate PDL1 expression and TME. Blood samples will be taken for PK and immune response studies. STI- ...
Learn about this cancer that forms from white blood cells called plasma cells. Treatments include medicines and bone marrow transplant.
The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival ...
"The cancer in this case is the immune system. So, often, we're trying to get the immune system to fight against the cancer. But in this case, the challenge ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!